The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Junior Miner Uncovers Gold-Rich Potential in Spain Breakthrough
Source: Streetwise Reports (08/27/2025)

Emerita Resources Corp. (EMO:TSX.V; EMOTF:OTCQB; LLJA:FSE) closed a US$25M financing as gold stays above US$3,300, advancing high-grade projects in Spain. Read more to find out what this means for the company's growth and ongoing exploration plans.

Investors Seek Big Gains From Explorer With High-Grade Copper, Silver
Source: Streetwise Reports (08/27/2025)

Metallic Minerals Corp. closes its flow-through share offering for proceeds of approximately CA$1.3 million, bringing the total proceeds financed from recent offerings to CA$8 million. Find out why one expert thinks the company's stock is undervalued and ready to grow.

Gold Explorer Discovers High-Grade Intercepts in British Columbia
Source: Streetwise Reports (08/27/2025)

Goliath Resources Ltd. (GOT:TSX.V; GOTRF:OTCQB; B4IF:FSE) hit 10.6 g/t gold over 22.82m at Surebet in BC's Golden Triangle, with a 100% drill hit rate and strong analyst and institutional support. Read more to find out how ongoing drilling, new discoveries, and growing investor confidence are shaping momentum at the Golddigger Project.

Gold Explorer Secures Full Ownership of High-Grade Nevada Project Near Major Discovery
Source: Streetwise Reports (08/27/2025)

Eminent Gold Corporation (EMNT:TSXV; EMGDF:OTCQB) finalized its Celts Project acquisition in Nevada, gaining full control of a high-grade system with up to 33 g/t gold and 158 g/t silver. Read more to find out how this strategically located project near a major discovery could shape the company's next exploration phase.

Healthcare AI Company Rebrands as Rocket Doctor AI to Pursue Growing Market Opportunities
Source: Streetwise Reports (08/27/2025)

Treatment.com AI Inc. has rebranded and reincorporated as Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) to reflect the integration of its proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc. Read why one analyst calls part of the company's offerings "Shopify for physicians."